Research Celcuity keeps cool amid questions about Revtorpyk launch timingBy Healthcare Propulsion StaffAugust 18, 20260 After investors blanched last month at a slower-than-expected launch timeline for Celcuity’s novel breast cancer med Revtorpyk, the company used…
